Even under idealized assumptions of highly effective or “sterilizing” immunity, maintaining herd immunity in practice is complicated by continual population turnover, global migration, and the ease of international travel, all of which allow for repeated reintroduction of pathogens into communities.
My letter is concerned with the effect of the flu vaccine on flu-related death. That’s the ultimate endpoint of interest for vaccine effectiveness (VE) research, yet it is not captured in most studies that employ the test-negative design.
Over the years, authors have shared a similar analytical strategy: Early respiratory events were considered differently from later respiratory events (on the assumption that no effect is expected until immunity is built up). “Early” has typically been within two weeks post-vaccination.
Was My Paper on Flu Vaccine Studies a “Hot Potato” for Editors? Continue Reading
The prevailing understanding of poliovirus pathogenesis posits that the virus, following intestinal infection, gains access to the central nervous system through viremia and subsequent crossing of the blood-brain barrier. However, this model fails to explain several features of the historical polio epidemic.
Working with military intelligence and pharmaceutical companies, Fauci and his colleagues eventually hatched an audacious plan to delay natural immunity for ten months as they awaited both the election and the viable release of the injectable product called a vaccine.
CDC Principal Deputy Director Ralph Abraham argued that “framing measles as an American policy failure is inaccurate and misleading,” asserting that resources including vaccines and therapeutics have been surged nationwide and that the current measles situation reflects broader global trends.
The narratives of the pandemic travelled across borders. Accountability cannot be allowed to vanish between them. The record belongs to the people who bore the consequences—and they should not have to wait for another country to tell them what happened.
Chairman Rand Paul has been collecting and releasing documents as part of the ongoing (what is it now, 6 bloody years?) investigation into SARS-2 origins. It is “largely accepted” that SARS-2 is of natural origin.
The FDA’s first EUA for a Covid-19 vaccine rested on its determination that the benefits of the Pfizer–BioNTech vaccine outweighed its risks. Yet the trial report did not bring those together within a common framework. I did—and what I found was startling.
The Full Risk–Benefit Balance Behind the First Covid-19 Vaccine Continue Reading
Senator Rand Paul’s (R-KY) efforts to compel honesty from Anthony Fauci, and Senator Ron Johnson’s (R-WI) indefatigable efforts to chronicle shot harm (they knew the risks), are both deeply honorable. But they are only the beginning of necessary efforts.
It’s hard to generalize, but when reversals are based on better quality evidence, we should presume they’re in the public interest. However, when they are based on manufacturers pushing for a new market and other invested agencies, can we be sure?
Cycles of Enthusiasm, Reversal, and Revival in Medical Practice Continue Reading
Seeing Sunday’s New York Times headline titled “Confidential Report Calls for Sweeping Changes to Track Covid Vaccine Harms,” a question flashed in the minds of even the defenders of legacy vaccine policy – is the NY Times about to dismiss the Covid vaccine-injured?
Correcting the New York Times ACIP Reporting on Vaccine Injury Continue Reading
Search 4,000+ articles & events
